06 Mar , 2026 By : Debdeep Gupta
PB Fintech stock fell to as low as Rs 1,442 in the opening trade, down more than 2 percent from the previous close. Around 48.4 lakh shares of PB Fintech changed hands in the block deal window at a price of Rs 1,435.1 per share. The transaction value works out to roughly Rs 695 crore.
PB Fintech shares slipped in early trade on Friday after a large block deal worth about Rs 695 crore took place in the pre-market block deal window. The stock fell to as low as Rs 1,442 in the opening trade, down more than 2 percent from the previous close.
Around 48.4 lakh shares of PB Fintech changed hands in the block deal window at a price of Rs 1,435.1 per share. The transaction value works out to roughly Rs 695 crore. The identities of the buyers and sellers involved in the deal were not immediately known.
PB Fintech shares had ended Thursday’s session at Rs 1,4728., down 0.5 percent for the day. The stock has gained about 4.2 percent over the past one year, underperforming the Nifty 50’s roughly 9.9 percent rise during the same period. The company currently commands a market capitalisation of more than Rs 67,700 crore.
Earlier this month, Kotak Institutional Equities upgraded its rating on PB Fintech from 'Reduce' to 'Add', citing an improved risk-reward profile for investors. The brokerage noted that the stock had underperformed in recent months despite strong underlying business performance.
Kotak analysts said earlier concerns around a proposed international insurance distribution acquisition and upcoming regulations on insurance commissions had weighed on sentiment. With some of these uncertainties easing, the brokerage believes the stock now offers a more favourable long-term proposition. Kotak retained its fair value estimate of Rs 1,725 per share.
PB Fintech, the parent company of Policybazaar, reported strong growth in its core insurance business in the December quarter. The company’s new business premium rose 45 percent year-on-year during the third quarter of FY2026, driven mainly by strong traction in term and health insurance products. Commissions remained stable at around 20.8 percent during the period.
0 Comment